[Other] Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer |
|
This post will be closed automatically in 2026-08-17 02:29
Reward20points
|
post
reply
points
9011
20
[Single chapter]Face Super-Resolution Model Based on Diffusion Model
20
[Single chapter]Face Super-Resolution Model Based on Diffusion Model
20
Mortality and deciding factors for no revascularization in cardiogenic shock patients; a cross sectional study
20
Trait Activation Theory: A Review of the Literature and Applications to Five Lines of Personality Dynamics Research
20
Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer
